Renalytix RNLXY
OTC RNLXY
$3.70 -0.09 (-2.37%)
At close: Nov 6, 2026 · 4:00 PM EST

Renalytix (RNLXY) Net Income towards Common Stockholders (2020 - 2024)

Updated

Renalytix's Net Income towards Common Stockholders was -$4.73 million in fiscal Q1 2025 (quarter ended Sep 30, 2024), compared with -$10.15 million a year earlier.

Analysis

Renalytix (RNLXY) Net Income towards Common Stockholders (2020 - 2024) Analysis & Trends

On a trailing twelve-month basis, Renalytix's Net Income towards Common Stockholders was -$28.03 million through Sep 30, 2024; for FY2024 (ended Jun 30, 2024), it came in at -$33.46 million.

  • In earlier fiscal years, Net Income towards Common Stockholders was -$45.61 million in FY2023, -$45.28 million in FY2022, -$34.73 million in FY2021 and -$9.84 million in FY2020.
  • The fiscal Q1 2025 figure marks the highest quarterly Net Income towards Common Stockholders in data going back to fiscal Q2 2021.
  • Per Business Quant data, RNLXY's Net Income towards Common Stockholders in the three fiscal quarters before Q1 2025 was -$7.07 million (Q4 2024), -$7.74 million (Q3 2024) and -$8.49 million (Q2 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -4.73 Mn
Jun 30, 2024 -7.07 Mn
Mar 31, 2024 -7.74 Mn
Dec 31, 2023 -8.49 Mn
Sep 30, 2023 -10.15 Mn
Jun 30, 2023 -11.10 Mn
Mar 31, 2023 -12.11 Mn
Dec 31, 2022 -10.44 Mn
Sep 30, 2022 -11.95 Mn
Jun 30, 2022 -5.15 Mn
Mar 31, 2022 -14.70 Mn
Dec 31, 2021 -15.32 Mn
Sep 30, 2021 -10.11 Mn
Jun 30, 2021 -9.82 Mn
Mar 31, 2021 -8.78 Mn
Dec 31, 2020 -8.91 Mn
API Access

Renalytix Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RNLXY&period=max&api_key=YOUR_API_KEY